INTRODUCTION: Compared with coronary heart disease and stroke, the association between SES and the risk of heart failure is less well understood. METHODS: In 12,646 participants of the Atherosclerosis Risk in Communities Study cohort free of heart failure history at baseline (1987-1989), the association of income, educational attainment, and area deprivation index with subsequent heart failure-related hospitalization or death was examined while accounting for cardiovascular disease risk factors and healthcare access. Because SES may affect threshold of identifying heart failure and admitting for heart failure management, secondarily the association between SES and N-terminal pro-b-type natriuretic peptide (NT-proBNP) levels, a marker reflecting cardiac overload, was investigated. Analysis was conducted in 2016. RESULTS: During a median follow-up of 24.3 years, a total of 2,249 participants developed heart failure. In a demographically adjusted model, the lowest-SES group had 2.2- to 2.5-fold higher risk of heart failure compared with the highest SES group for income, education, and area deprivation. With further adjustment for time-varying cardiovascular disease risk factors and healthcare access, these associations were attenuated but remained statistically significant (e.g., hazard ratio=1.92, 95% CI=1.69, 2.19 for the lowest versus highest income), with no racial interaction (p>0.05 for all SES measures). Similarly, compared with high SES, low SES was associated with both higher baseline level of NT-proBNP in a multivariable adjusted model (15% higher, p<0.001) and increase over time (~1% greater per year, p=0.023). CONCLUSIONS: SES was associated with clinical heart failure as well as NT-proBNP levels inversely and independently of traditional cardiovascular disease factors and healthcare access.
INTRODUCTION: Compared with coronary heart disease and stroke, the association between SES and the risk of heart failure is less well understood. METHODS: In 12,646 participants of the Atherosclerosis Risk in Communities Study cohort free of heart failure history at baseline (1987-1989), the association of income, educational attainment, and area deprivation index with subsequent heart failure-related hospitalization or death was examined while accounting for cardiovascular disease risk factors and healthcare access. Because SES may affect threshold of identifying heart failure and admitting for heart failure management, secondarily the association between SES and N-terminal pro-b-type natriuretic peptide (NT-proBNP) levels, a marker reflecting cardiac overload, was investigated. Analysis was conducted in 2016. RESULTS: During a median follow-up of 24.3 years, a total of 2,249 participants developed heart failure. In a demographically adjusted model, the lowest-SES group had 2.2- to 2.5-fold higher risk of heart failure compared with the highest SES group for income, education, and area deprivation. With further adjustment for time-varying cardiovascular disease risk factors and healthcare access, these associations were attenuated but remained statistically significant (e.g., hazard ratio=1.92, 95% CI=1.69, 2.19 for the lowest versus highest income), with no racial interaction (p>0.05 for all SES measures). Similarly, compared with high SES, low SES was associated with both higher baseline level of NT-proBNP in a multivariable adjusted model (15% higher, p<0.001) and increase over time (~1% greater per year, p=0.023). CONCLUSIONS:SES was associated with clinical heart failure as well as NT-proBNP levels inversely and independently of traditional cardiovascular disease factors and healthcare access.
Authors: Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner Journal: Circulation Date: 2015-12-16 Impact factor: 29.690
Authors: Melissa J Azur; Elizabeth A Stuart; Constantine Frangakis; Philip J Leaf Journal: Int J Methods Psychiatr Res Date: 2011-03 Impact factor: 4.035
Authors: Johan P Mackenbach; Irina Stirbu; Albert-Jan R Roskam; Maartje M Schaap; Gwenn Menvielle; Mall Leinsalu; Anton E Kunst Journal: N Engl J Med Date: 2008-06-05 Impact factor: 91.245
Authors: Saif S Rathore; Frederick A Masoudi; Yongfei Wang; Jeptha P Curtis; JoAnne M Foody; Edward P Havranek; Harlan M Krumholz Journal: Am Heart J Date: 2006-08 Impact factor: 4.749
Authors: Ijaz A Khan; Jeffrey Fink; Caitlin Nass; Hegang Chen; Robert Christenson; Christopher R deFilippi Journal: Am J Cardiol Date: 2006-03-31 Impact factor: 2.778
Authors: Alan Maisel; Christian Mueller; Kirkwood Adams; Stefan D Anker; Nadia Aspromonte; John G F Cleland; Alain Cohen-Solal; Ulf Dahlstrom; Anthony DeMaria; Salvatore Di Somma; Gerasimos S Filippatos; Gregg C Fonarow; Patrick Jourdain; Michel Komajda; Peter P Liu; Theresa McDonagh; Kenneth McDonald; Alexandre Mebazaa; Markku S Nieminen; W Frank Peacock; Marco Tubaro; Roberto Valle; Marc Vanderhyden; Clyde W Yancy; Faiez Zannad; Eugene Braunwald Journal: Eur J Heart Fail Date: 2008-08-29 Impact factor: 15.534
Authors: Laura R Loehr; Wayne D Rosamond; Charles Poole; Ann Marie McNeill; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless; Gerardo Heiss Journal: Circ Heart Fail Date: 2009-01 Impact factor: 8.790
Authors: Edward P Havranek; Mahasin S Mujahid; Donald A Barr; Irene V Blair; Meryl S Cohen; Salvador Cruz-Flores; George Davey-Smith; Cheryl R Dennison-Himmelfarb; Michael S Lauer; Debra W Lockwood; Milagros Rosal; Clyde W Yancy Journal: Circulation Date: 2015-08-03 Impact factor: 29.690
Authors: Michelle L Snyder; Shelly-Ann Love; Paul D Sorlie; Wayne D Rosamond; Carmen Antini; Patricia A Metcalf; Shakia Hardy; Chirayath M Suchindran; Eyal Shahar; Gerardo Heiss Journal: Popul Health Metr Date: 2014-04-10
Authors: Nirav Patel; Mary Cushman; Orlando M Gutiérrez; George Howard; Monika M Safford; Paul Muntner; Raegan W Durant; Sumanth D Prabhu; Garima Arora; Emily B Levitan; Pankaj Arora Journal: JCI Insight Date: 2019-06-04
Authors: Stephen Y Wang; Andy S L Tan; Brian Claggett; Alvin Chandra; Sameed Ahmed M Khatana; Pamela L Lutsey; Anna Kucharska-Newton; Silvia Koton; Scott D Solomon; Ichiro Kawachi Journal: JAMA Cardiol Date: 2019-12-01 Impact factor: 14.676
Authors: Nirav Patel; Orlando M Gutiérrez; Garima Arora; George Howard; Virginia J Howard; Suzanne E Judd; Sumanth D Prabhu; Emily B Levitan; Mary Cushman; Pankaj Arora Journal: Int J Cardiol Date: 2019-02-21 Impact factor: 4.164
Authors: Doris Winitzki; Helena U Zacharias; Jennifer Nadal; Seema Baid-Agrawal; Elke Schaeffner; Matthias Schmid; Martin Busch; Manuela M Bergmann; Ulla Schultheiss; Fruzsina Kotsis; Helena Stockmann; Heike Meiselbach; Gunter Wolf; Vera Krane; Claudia Sommerer; Kai-Uwe Eckardt; Markus P Schneider; Georg Schlieper; Jürgen Floege; Turgay Saritas Journal: Kidney Int Rep Date: 2022-02-14